November 30, 2015

Approximately 35% received the flu shot at a doctor’s office, followed by 27% who received it at a pharmacy. 

November 30, 2015

The six-month pilot program included 270 HealthPartners members who had a diagnosis of hypertension and a prescription for medication to lower blood pressure at a Sterling pharmacy. 

November 30, 2015

The pilot’s findings come at a time when the CDC noted that 1-in-3 primary care physicians and nurse practitioners do not know what PrEP is despite the promise it has shown to prevent HIV among high-risk groups. 

November 30, 2015

For every immunization, including flu shots, administered at a Walgreens pharmacy, the value of two life-saving vaccines will be donated to a child in a developing country.

November 25, 2015

Aurobindo’s sildenafil tablets are a generic version of Pfizer’s Revatio, which treats pulmonary arterial hypertension. 

November 25, 2015

Despite pre-exposure prophylaxis pills’ efficacy in preventing HIV that’s transmitted sexually or through use of injected drugs, only one-in-three primary care physicians and nurses have heard of it. 

November 25, 2015

Novartis’ Fluad is a trivalent flu vaccine that contains the adjuvant MF59, an emulsion of squalene oil in water, and is aimed at improving immune response among patients 65 years of age and older. 

November 25, 2015

The drug, according to IMS Health data for the 12 months eneding Sept. 2015, had combined brand and generic sales of $457 million. 

November 24, 2015

The Medicare savings that the American College of Physicans says could be saved by focusing on generics is estimated to total $1.4 billion. 

November 24, 2015

Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months. 

November 24, 2015

Mylan has introduced its generic of Jazz Pharmaceuticals’ schizophrenia treatment. 

November 24, 2015

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

November 23, 2015

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

November 23, 2015

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies. 

November 23, 2015

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

November 23, 2015

Greenstone received final approval from the Food and Drug Administration for its generic Zyvox. 

November 23, 2015

Earlier this year, California and Oregon passed laws allowing pharmacists to prescribe birth control to patients. As the measure is set to roll out in the first half of 2016, the New York Times has reported on the growing trend of states allowing pharmacists to prescribe contraceptives, noting its potential impact on medically underserved populations. “I feel strongly that this is what’s best for women’s health in the 21st century, and I also feel it will have repercussions for decreasing poverty because one of the key things for women in poverty is unintended pregnancy,” Oregon Rep. Knute Buehler, the Republican who sponsored Oregon’s law, told NYT. (New York Times)

November 23, 2015

Perrigo is buying a Crohn’s disease treatment from AstraZeneca. 

November 23, 2015

A 15-member board composed will govern the combined company and Pfizer CEO Ian Read will be CEO of the combined company and Allergan CEO Brent Saunders will be the president and COO. 

November 20, 2015

The average annual cost of a specialty medication used on a chronic basis exceeded $53,000 in 2013, which is more than the median U.S. household income, AARP noted. 

November 20, 2015

Alchemia’s shareholders approved the sale of Fondaparinux at the company’s annual general meeting held on Nov. 10.

November 20, 2015

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

November 20, 2015

In preparation for this launch, Mission has expanded its sales force and increased promotional efforts to reach more primary care and internal medicine healthcare providers.

November 20, 2015

Mylan's acquisition of Jai Pharma brings Mylan a broad women's care portfolio, strong technical capabilities and dedicated hormone manufacturing.